⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9161862 | 0.76 | — | — | |
| SCHEMBL6370939 | 0.72 | — | — | |
| SCHEMBL28950286 | 0.71 | — | — | |
| SCHEMBL5327875 | 0.69 | — | — | |
| SCHEMBL8769845 | 0.69 | — | — | |
| SCHEMBL1725965 | 0.69 | — | — | |
| SCHEMBL8769966 | 0.66 | — | — | |
| SCHEMBL15847476 | 0.65 | — | — | |
| SCHEMBL150943 | 0.64 | — | — | |
| SCHEMBL1619192 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12042479-B2 | Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders | INMED PHARMACEUTICALS INC. | 2024-07-23 | — | — | US | disclosed |
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240238427-A1 | METHODS OF TREATING AN EYE DISORDER | KODIAK SCIENCES INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239751-A1 | PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF | BRIDGEBIO GENE THERAPY RESEARCH, INC. | 2024-07-18 | — | — | US | disclosed |
| CN-118344348-A | Heterocyclic substituted quinazoline and preparation method and application thereof | 苏州泽璟生物制药股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20240228480-A1 | PROCESSES FOR PREPARING PYRROLOPYRIDINE-ANILINE COMPOUNDS | CURIA GLOBAL, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240218011-A1 | GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF | FIREFLY BIO, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240218021-A1 | CYCLIN INHIBITORS | CIRCLE PHARMA, INC. | 2024-07-04 | — | — | US | disclosed |
| US-12024731-B2 | Methods and enzyme catalysts for the synthesis of non-canonical amino acids | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240208973-A1 | TETRACYCLIC COMPOUNDS FOR TREATING BRAIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-06-27 | — | — | US | disclosed |
| EP-0863866-B1 | BUTYRATE PRODRUGS OF LACTIC ACID | VERTEX PHARMA (US) | 2001-05-02 | — | — | EP | disclosed |
| US-6225350-B1 | ADMINISTERING BUTYRATE PRODRUG FOR THERAPY OF CYSTIC FIBROSIS | VERTEX PHARMACEUTICALS, INC. | 2001-05-01 | — | — | US | disclosed |
| EP-1071681-A1 | NITROXYL DERIVATIVES WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS INITIATORS FOR RADICAL POLYMERISATION | Ciba SC Holding AG (CH) | 2001-01-31 | — | — | EP | disclosed |
| EP-0969828-A1 | BUTYRATE PRODRUGS DERIVED FROM LACTIC ACID | Vertex Pharmaceuticals Incorporated (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999046261-A1 | NITROXYL DERIVATIVES WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS INITIATORS FOR RADICAL POLYMERISATION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-09-16 | — | — | WO | disclosed |
| US-5912269-A | SICKLE CELL SYNDROME, ANTICARCIOGENIC AGENTS | VERTEX PHARMACEUTICALS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| US-5883123-A | GAMMA GLOBIN AND FETAL HEMOGLOBIN, SICKLE CELL SYNDROME AND THALASSEMIA SYNDROME | VERTEX PHARMACEUTICALS, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5880152-A | INFLAMMATORY BOWEL DISEASE | VERTEX PHARMACEUTICALS, INC. (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0891986-A1 | Polymerizable compositions containing alkoxyamine compounds derived from nitrogen oxide | Ciba SC Holding AG (CH) | 1999-01-20 | — | — | EP | disclosed |
| WO-1998040064-A1 | BUTYRATE PRODRUGS DERIVED FROM LACTIC ACID | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-09-17 | — | — | WO | disclosed |